obesity drug news today october 2025 glp-1 Outlook for in 2025: more than a transition year Pharma Giants Bet on Next-Generation
Description
Taken together, the Magruder et al
Why this story matters now Even though evidence is still early and more research is needed, GLP-1 medications are now part of a broader conversation about cancer prevention, survivorship, treatment tolerance, and long-term health after breast cancer
doi: 10.3389/fendo.2018.00584 [DOI] [PMC free article] [PubMed] [Google Scholar] 34.Gaykema RP, Newmyer BA, Ottolini M, et al
Shotsy color-codes every data point on your weight chart by the dose you were taking at the time, letting you spot the exact moments where a titration change made a visible difference
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC
